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Abstract We have analyzed five mutant alleles of two cyclin-
dependent kinases from Arabidopsis thaliana, CDC2aAt and
CDC2bAt, in Schizosaccharomyces pombe. Two of the five
mutant alleles produced similar phenotypes for both cyclin-
dependent kinases. The other three mutants caused phenotypes
dependent on the particular cyclin-dependent kinase. Of all the
mutant alleles, only two were found to possess a detectable
kinase activity. Our mutational analysis lends further support for
CDC2aAt being the true orthologue of the yeast cdc2.
CDC2bAt, even though quite divergent from S. pombe cdc2,
still retains the ability to interact with at least some essential cell
cycle regulators, suggesting some functional homology with the
yeast protein. Additionally, we demonstrated that the three
amino acid deletion in the DL50 mutants results in the loss of the
ability to interact with the suc1/CKS1 proteins.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
The control of cell cycle progression in eukaryotic cells is
mainly exerted at two transition points. One in late G1, before
DNA synthesis, and one at the G2/M boundary. Cyclin-de-
pendent kinases (CDKs) regulate the passage through these
control points by the phosphorylation of key substrates. CDK
activity requires binding of the CDKs with regulatory pro-
teins, called cyclins, and the phosphorylation of a Thr residue
located in the ‘T loop’. Activated CDKs may be inhibited by
the phosphorylation of two residues (Thr-14 and Tyr-15) lo-
cated in the catalytic cleft and by the binding of the so-called
cyclin-dependent kinase inhibitors. Most of these regulatory
steps are conserved from yeast to human [1].
The two CDKs characterized so far in Arabidopsis thaliana,
CDC2aAt and CDC2bAt [2,3], share 60% and 56% identity
with the ¢ssion yeast cdc2 protein, respectively, and 56% iden-
tity between themselves. Both CDC2aAt and CDC2bAt have
a unique motif in the cyclin-binding domain (PSTAIRE and
PPTALRE, respectively), suggesting that each binds to di¡er-
ent cyclins. CDC2aAt can partially complement (for just two
rounds of cell division) the temperature sensitive mutant cdc2-
33 of Schizosaccharomyces pombe, whereas CDC2bAt cannot
[4]. The only conclusion that may be drawn from these results
is that CDC2aAt, but not CDC2bAt, is able to substitute for
some unidenti¢ed function(s) of the multifunctional CDC2
kinase that is impaired by the cdc2-33 mutation. The question
remains about the identity of that (those) function(s) and
about the pro¢ciency of both Arabidopsis CDKs as far as
other functions are concerned.
Their di¡erential behavior suggests that CDC2aAt and
CDC2bAt play a unique role in the regulation of the cell cycle
rather than being redundant. However, the individual roles of
CDC2aAt and CDC2bAt in the cell cycle control remain to be
determined. The use of dominant mutants provides a way to
address this problem. Previously, two mutations were intro-
duced into CDC2aAt. One expected to inactivate the kinase
(CDC2aAt.DN) and one that abolished the inhibitory phos-
phorylation of the Thr-14 and Tyr-15 residues (CDC2aA-
t.AF). Their e¡ects on the cell cycle were analyzed both in
¢ssion yeast and in planta [5]. Here we attempted to extend
this work by constructing three additional mutant alleles of
CDC2aAt. The mutations were chosen by analogy with dom-
inant negative mutations identi¢ed in the ¢ssion yeast cdc2
gene [6]. In Schizosaccharomyces pombe, the mutants inter-
fered with three distinct elements of the cell cycle control:
(i) entry into mitosis (cdc2.DL50), (ii) progression through
mitosis (cdc2.DL41) and (iii) coordination of the DNA syn-
thesis phase with mitosis (cdc2.DL36). Although CDC2bAt
fails to complement the cdc2-33 mutation, this fact does not
preclude that it may share some of the cell cycle functions
with cdc2. Because the residues a¡ected by the yeast muta-
tions described above are conserved in CDC2bAt, we intro-
duced the analogous mutations into CDC2bAt as well.
As a ¢rst step in the analysis of these new mutant CDK
alleles, all were expressed in ¢ssion yeast and their e¡ects
upon cell cycle progression were compared with those de-
scribed for the original ¢ssion yeast cdc2 mutants. As exper-
imental system, ¢ssion yeast o¡ers a number of advantages
for comparing di¡erent CDKs and their alleles, such as the
availability of promoters allowing inducible expression to dif-
ferent levels and the possibility to analyse the e¡ect of the
mutant proteins in the absence of the endogenous cdc2 activ-
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ity. Moreover, the identi¢cation of cell cycle mutant pheno-
types in ¢ssion yeast is a relatively straightforward process. A
cell cycle arrest leads typically to cell elongation (cdcÿ pheno-
type), whereas an advancing of mitosis produces typical cells
with a reduced cell size (wee phenotype) when compared to
wild-type cells.
We found that two of the three new mutant alleles of
CDC2aAt (CDC2aAt.DL41 and CDC2bAt.DL50) caused an
alteration of the cell cycle almost indistinguishable from those
observed for the corresponding yeast cdc2 mutants, whereas
the third one (CDC2aAt.DL36) displayed only a partial sim-
ilarity. We also show that expression of CDC2bAt, and four
of the ¢ve mutant alleles thereof, blocked the cell cycle in G2,
whereas the CDC2bAt.DL50 allele caused a mitotic catastro-
phe phenotype identical to that of cdc2.DL50 and
CDC2aAt.DL50 mutant genes.
2. Materials and methods
2.1. Site-directed mutagenesis
CDC2aAt and CDC2bAt cDNAs were cloned in pGem7Z-fÿ
(Promega, Madison, WI, USA) and in pUC18, respectively. The
site-directed mutagenesis was performed with the use of the ExSite
PCR-based, site-directed mutagenesis kit (Stratagene, La Jolla, CA,
USA) according to the manufacturer’s instructions. The primers used
to introduce the mutations were (the mutagenized residues being
underlined): 5P-TTGTCAGGACATTTACTCAT-3P and 5P-GGATA-
CCGAATGCTCTG-3P for CDC2aAt.DL41, 5P-TCTCTGGTACCG-
AGCAC-3P and 5P-ATAACAACCTCATGAGTAAAT-3P for CDC2-
aAt.DL36, 5P-TATAAATCTGCTTTCCCTAAA-3P and 5P-AGAAG-
TTACCCCACGC-3P for CDC2aAt.DL50, 5P-ATTCGGGAAAGTC-
TACAAA-3P and 5P-GCTCCTTCTCCCGACCTT-3P for CDC2bA-
t.AF, 5P-AATTTGGGTCTTGGTCGT-3P and 5P-AGCAATCTTAA-
GAAGCTCTT-3P for CDC2bAt.DN, 5P-TCTTAAGTCTTATACG-
CATGA-3P and 5P-AGAACAGTAAAAGCACGAC-3P for CDC2-
bAt.DL41, 5P-TTCTTTGGTATAGAGCTCCT-3P and 5P-TAACAA-
TCTCATGCGTATAA-3P for CDC2bAt.DL36 and 5P-TGGCATGT-
TTACCCTAA-3P and 5P-TGTGGAAACACCCG-3P for CDC2b-
At.DL50. The ¢delity of the mutagenesis was con¢rmed by sequenc-
ing.
2.2. Plasmids and recombinant DNA
CDC2aAt, CDC2aAt.AF and CDC2aAt.DN cDNAs were transcrip-
tionally fused to the nmt1 promoter in the ¢ssion yeast expression
vector pREP3 [7]. The CDC2aAt.DL41, CDC2aAt.DL36 and
CDC2aAt.DL50 cDNAs were cloned in pREP3 by replacing the
NcoI-BamHI fragment of the CDC2aAt cDNA with the respective
fragments carrying the mutations. To clone CDC2bAt cDNA in
pREP3, one of the constructs above was opened with NcoI, trimmed
with mung bean exonuclease and subsequently cleaved with XmaI.
The CDC2bAt cDNA was then ligated into the vector as HpaI-
XmaI fragment. All the other cDNAs carrying the CDC2bAt muta-
tions were cloned into pREP3 replacing the SalI-BamHI fragment of
CDC2bAt with the respective fragments carrying the mutations.
For cloning CDC2aAt alleles in pREP41 [8], a NcoI linker was
ligated to the ¢lled in NdeI site and the respective cDNAs were cloned
as NcoI-XmaI fragments into the NcoI-XmaI site of pREP41.
CDC2bAt cDNA was ligated as KpnI (blunted)-BamHI fragment
into the NdeI (¢lled in)-BamHI site of pREP41. All the CDC2bAt
mutations were cloned, replacing the SalI-BamHI of the construct
above with the respective fragments carrying the mutations.
2.3. Two hybrid assay
Vectors and strains used were provided with the Matchmaker two
hybrid system kit (Clontech, Palo Alto, CA, USA). The preys and
CDC2aAt bait were cloned as described [9]. The CDC2aAt.DL50 bait
was constructed by cloning the CDC2aAt.DL50 cDNA as NcoI
(¢lled)-XmaI fragment into the pGBT9 vector opened with EcoRI
(¢lled)-XmaI. The baits and preys were co-transformed into the bud-
ding yeast HF7c strain (MATa ura3-52 his3-200 ade2-101 lys 2-801
trp1-901 leu2-3,112 gal4-542 gal80-538 LYS2: :GAL1UAS-GAL1TATA-
HIS3 URA3: :GAL417MERS3X-CYC1TATA-LacZ) and the association
between the baits and the preys was assessed by the ability of the co-
transformed strains to grow on histidine lacking medium.
2.4. Fission yeast strains and methods
The two temperature sensitive cdc2 mutant strains used were cdc2-
33 leu1-32 hÿ and cdc2-L7 leu1-32 hÿ [10]. Basic ¢ssion yeast techni-
ques were performed as described [11].
2.5. Immuno blots and H1 kinase assays
Cell extracts were prepared [11] and histone H1 kinase activity in
crude protein extracts was assayed [12]. Histone H1 kinase assays and
immunoblotting of the CDK complexes, puri¢ed from crude extracts
by p13suc1 a⁄nity chromatography, were done according to [9]. Phos-
phorylated histone H1 was visualized and quanti¢ed through Phos-
phorImager scanning (Molecular Dynamics, Eugene, OR, USA).
3. Results
A map of the mutations introduced into the two A. thaliana
CDKs is presented in Fig. 1. The wild-type and mutant alleles
were cloned under the control of the nmt1 promoter and its
attenuated derivative nmt1-T4 in the pREP3 and pREP41
expression vectors, respectively [7,8]. The nmt1 promoter is
repressed when cells are grown in the presence of thiamine
and can be induced by growing the cells in thiamine-free me-
dium. For the analysis, the designed constructs were trans-
formed into two temperature sensitive ¢ssion yeast strains,
cdc2-33 and cdc2-L7. The growth of the transformed strains
was analyzed to assess the ability of the mutant alleles to
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Table 1
Overview of overexpression analysis of the A. thaliana wild-type and mutant CDK alleles in ¢ssion yeast
Alleles Complements
cdc2-33
Phenotype in cdc2-33
at permissive temperatures
H1 kinase activity in
cdc2-L7 at 36‡Ca
H1 kinase activity in cdc2-33
at 25‡Cb
CDC2aAt + Wee 42% Decrease
CDC2aAt.AF + Severe wee 96% Increase
CDC2aAt.DN 3 Interphase arrest, oversized nuclei ^ Decrease
CDC2aAt.DL36 3 Interphase arrest ^ Decrease
CDC2aAt.DL41 3 Mitotic arrest 11% Decrease
CDC2aAt.DL50 3 Mitotic catastrophe 261% No change
CDC2bAt 3 Interphase arrest ^ Decrease
CDC2bAt.AF 3 Interphase arrest ^ Decrease
CDC2bAt.DN 3 Interphase arrest, oversized nuclei ^ Decrease
CDC2bAt.DL36 3 Interphase arrest ^ Decrease
CDC2bAt.DL41 3 Interphase arrest ^ Decrease
CDC2bAt.DL50 3 Mitotic catastrophe ^ Decrease
aThe increase upon induction
bIn comparison with non-induced cells
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restore or to interfere with cell division activity at the restric-
tive (36‡C) or permissive (25‡C) temperatures, respectively.
Cells stained with a DNA-binding £uorochrome were sub-
jected to further analysis by £uorescent microscopy and £ow
cytometry. Because the pREP3 vector gave a basal expression
level in the non-induced conditions, most analyses were done
with the pREP41 constructs.
3.1. E¡ect of CDC2aAt and CDC2bAt mutant alleles on the
cell cycle progression in yeast
Expression of the di¡erent A. thaliana CDK alleles in the
¢ssion yeast cdc2-33 strain grown under permissive conditions
interfered in di¡erent ways with cell cycle progression (Table
1). Expression of the wild-type CDC2aAt gene led to the
production of cells that divided at a reduced size (Fig. 2B)
in comparison to cells transformed with the control vector
(Fig. 2A), suggesting that mitosis is advanced in these cells.
Flow cytometric analysis showed an accumulation of 1C cells
(data not shown). Cells that overexpressed CDC2bAt were
more elongated (Fig. 2J). Flow cytometric analysis indicated
that most of the cells expressing CDC2bAt had a 2C DNA
content, pointing to an arrest in the G2 phase of the cell cycle
(data not shown).
Dephosphorylation of Tyr-15 in the ¢ssion yeast cdc2 leads
to entry into mitosis through activation of the kinase [13]. In
higher eukaryotes, an additional control is imposed through
phosphorylation of Thr-14 [14,15]. Expression in ¢ssion yeast
of CDC2aAt.AF, a mutant CDC2aAt in which the Thr-14 and
Tyr-15 residues are mutated into the two non-phosphorylat-
able residues Ala-14 and Phe-15, has already been described at
the morphological level [5]. A mixed population of cells was
observed with abnormal phenotypes resembling those de-
scribed for the ¢ssion yeast cdc2.F15 mutant [13]. We intro-
duced the AF mutation in CDC2bAt and expressed this mu-
tant allele in yeast. No morphological di¡erence with cells
expressing CDC2bAt was seen. Cells appeared elongated as
a consequence of continued growth in the absence of cell
division (data not shown).
The DN mutation, analyzed previously in a number of
PSTAIRE kinases including the ¢ssion yeast cdc2, inactivates
the kinase causing a cell cycle arrest [16]. As shown before [5],
expression of CDC2aAt.DN in ¢ssion yeast leads to a tight
cell cycle block in the interphase. We found additionally that
the majority of the cells contained oversized nuclei (Fig. 2C)
and that, at later time points, a subpopulation of cells devel-
oped grossly swollen nuclei that distended the yeast cell wall
(Fig. 2D). An identical phenotype was also observed upon
expression of CDC2bAt.DN (Fig. 2K).
The DL41 mutation was originally identi¢ed in a ¢ssion
yeast cdc2 mutant which, when expressed, blocked the cells
in mitosis. Cells showed condensed chromatin, elongated spin-
dles and aberrantly formed septa. The condensed chromatin
was often resolved in three bodies which were considered to
be the three chromosomes of ¢ssion yeast [6]. Similarly, ex-
pression of CDC2aAt.DL41 induced an accumulation of cells
with condensed chromatin and misplaced or partially formed
septa. The condensed chromatin was often resolved in three
bodies variously located within the cells (Fig. 2E). In agree-
ment with the observed phenotype, the cells were found by
£ow cytometric analysis to contain a 2C DNA content (data
not shown). At a higher expression level, CDC2aAt.DL41 led
to the formation of a population of elongated cells with cen-
trally located chromatin and misplaced or multiple septa (Fig.
2F). Thus, the expression of CDC2aAt.DL41 seems to block
cells at di¡erent points depending on the expression level. In
contrast, expression of CDC2bAt.DL41 induced a cell cycle
arrest similar to that observed for the expression of the wild-
type CDC2bAt gene.
Expression of cdc2.DL36 in ¢ssion yeast arrested the cell
division and caused an increase in the DNA content from 2C
up to 16C, resulting in highly elongated cells with very large
nuclei [16]. The phenotype obtained when CDC2aAt.DL36
was expressed in the yeast cells was partially di¡erent (Fig.
2G). The cells were strongly elongated, pointing to a cell cycle
arrest. Although DAPI staining revealed a clear increase in
the size of the nuclei, £ow cytometric analysis showed the
presence of only 2C cells (not shown). The phenotype of
CDC2bAt.DL36 was quite similar to that seen upon expres-
sion of CDC2bAt (data not shown).
The mutant cdc2.DL50 protein contains a deletion of three
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Fig. 1. Map of the characterized mutant alleles of CDC2aAt and CDC2bAt. The bar in the middle represents the complete coding region. The
amino acid sequences of the mutated regions (in one letter code) are given below and above the bar for the plant CDKs and ¢ssion yeast
cdc2, respectively. The dots above the sequence indicate the mutated amino acids with the arrows pointing to the corresponding changes.
A. Porceddua, et al./FEBS Letters 446 (1999) 182^188184
residues [6]. Deletion of this region in cdc2 leads to a mitotic
catastrophe. The cells enter mitosis prematurely when the S
phase is not yet completed with a rapid loss of viability as a
consequence [6]. Expression of CDC2aAt.DL50 induced also a
premature advancement into mitosis as can be deduced from
the small cell size after 24 h of induction (Fig. 2H). At a
higher expression level the phenotype looked even more se-
vere. A large proportion of cells were either anucleate, had
nuclei cut by septa or showed fragmented chromatin (Fig. 2I).
Flow cytometric analysis showed the appearance of di¡used
peaks at both sides of the typical 2C peak, likely to represent
a mixed population of cells with a 1C DNA content unable to
pass the cell size check point as a consequence of the reduced
cell size, and cells with a DNA content ranging between 1C
and 2C or 2C and 4C as a result of abnormal chromatin
segregation (data not shown). Surprisingly, a very similar phe-
notype was observed when CDC2bAt.DL50 was expressed in
the yeast cells (Fig. 2L).
3.2. Complementation of cdc2-33 with di¡erent alleles of
CDC2aAt and CDC2bAt
The wild-type proteins and the mutant isoforms were tested
for their ability to rescue the growth defect imparted by the
cdc2-33 mutation at the restrictive temperature of 36‡C. Upon
induction of the attenuated nmt1-T4 promoter at the permis-
sive temperature, cells were plated on inducing medium and
incubated at the restrictive temperature for 4 days. Only
CDC2aAt and CDC2aAt.AF were able to restore the growth
of the ¢ssion yeast cdc2-33 cells to an extent su⁄cient to form
colonies at the restrictive temperature (Table 1).
3.3. Determination of the speci¢c kinase activity associated
with the A. thaliana CDKs
The speci¢c kinase activity associated with the mutant A.
thaliana kinases was determined in protein extracts prepared
from the ¢ssion yeast cdc2-L7 strain transformed with the
corresponding expression cassettes. This strain was reported
to have a negligible CDK activity at 37‡C [12], so the kinase
activity measured at this temperature is mainly determined by
the A. thaliana CDKs. All of the transformed strains were
grown in medium without thiamine for 16 h at the permissive
temperature of 25‡C to induce the nmt1 promoter. Control
cultures were grown in the same conditions but in the pres-
ence of thiamine. After protein extraction, the CDK activity
was determined at 37‡C in crude protein extracts with histone
H1 as a substrate [12].
CDC2aAt, CDC2aAt.AF and CDC2aAt.DL50 showed a
readily detectable kinase activity as manifested by an increase
of the signals upon induction (approximately 1.4-, 2- and 3.6-
fold, respectively) (Table 1). Only a marginal increase was
observed in case of CDC2aAt.DL41 expression (11%). None
of the CDC2bAt proteins, including wild-type, showed any
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Fig. 2. A^L: Cytological analysis of the yeast cells expressing the mutant alleles of CDC2aAt and CDC2bAt at 25‡C. REP41 and REP3 vectors
were used to express the wild-type and mutant alleles of CDC2aAt and CDC2bAt. After the beginning of the induction of expression (0 time
point), the samples were taken at di¡erent time points up to 38 h. The nuclei were stained with DAPI and the cells were analyzed microscopi-
cally as described in Section 2. Cells were maintained in exponential growth during the course of the experiment. (A) REP41 (38 h); (B)
REP41/CDC2aAt (24 h); (C) REP41/CDC2aAt.DN (24 h). (D) REP41/CDC2aAt.DN (38 h); (E) REP41/CDC2aAt.DL41 (24 h); (F) REP3/
CDC2aAt.DL41 (38 h); (G) REP3/CDC2aAt.DL36 (24 h); (H) REP41/CDC2aAt.DL50 (24 h); (I) REP3/CDC2aAt.DL50 (24 h); (J) REP3/
CDC2bAt (24 h); (K) REP41/CDC2bAt.DN (38 h); (L) REP41/CDC2bAt.DL50 (38 h).
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detectable kinase activity upon overproduction in the cdc2-L7
strain (Table 1).
3.4. Determination of the total histone H1 kinase activity in
cdc2-33 background
To correlate the above described phenotypes with changes
in the total CDK activity, we analyzed the histone H1 kinase
activity in the strains used for the cytological studies. Protein
extracts were prepared from the yeast cdc2-33 strains trans-
formed with the di¡erent pREP41 constructs grown at the
permissive temperature under inducing and non-inducing con-
ditions. Protein extracts were prepared from cells harvested
one generation time before the ¢rst changes in cell division
were observed (16 h after the removal of thiamine). The as-
says were performed at the permissive temperature (25‡C)
with CDK complexes partially puri¢ed by p13suc1-a⁄nity
chromatography [17].
For the CDC2aAt alleles, an increase of histone H1 kinase
activity was only observed in case of expression of CDC2aA-
t.AF (Table 1). Expression of CDC2aAt.DN and
CDC2aAt.DL36 strongly reduced the total CDK activity.
CDC2aAt and CDC2aAt.DL41, when overexpressed in yeast,
also compromized the total CDK activity, though less than
CDC2aAt.DN. Unexpectedly, expression of CDC2aAt.DL50
in the cdc2-33 background seemed to have almost no in£uence
on the total CDK activity, in spite of the high speci¢c kinase
activity associated with this allele (see above). The expression
of the CDC2bAt alleles in the cdc2-33 strain induced a reduc-
tion in the total CDK activity (data not shown).
3.5. Impact of the DL50 mutation on the interaction of
CDC2aAt with the ¢ssion yeast suc1 protein and its
A. thaliana homologue CKS1At
The apparent discrepancy between the high kinase activity
associated with CDC2aAt.DL50 on the one hand and the
absence of any increase in the total CDK activity upon its
expression in yeast cells on the other hand, prompted us to
further investigate the nature of the DL50 mutation. The ami-
no acids deleted in DL50 are located within the region in-
volved in the interaction of human CDK2 with the CKS1Hs
protein [18]. CKS1Hs is a member of a conserved family of
small proteins (suc1/CKS1) binding tightly to many but not
all CDKs. The current view is that they may function as
docking factors mediating the interaction of CDKs with phos-
phoproteins [19]. The suc1/CKS1 proteins are routinely used
to partially purify CDK containing complexes from crude
extracts because of their high a⁄nity for CDKs. We specu-
lated that by using p13suc1 beads to measure the kinase activ-
ity, the complexes containing CDC2aAt.DL50 could have
been lost. To verify this hypothesis, we tested in vitro the
ability of CDC2aAt.DL50 to bind p13suc1. Fig. 3 shows the
result of an immunoblot with an anti-CDC2aAt antibody of
p13suc1-puri¢ed complexes: no CDC2aAt.DL50 protein was
recovered by p13suc1 a⁄nity chromatography in contrast to
CDC2aAt, which was e⁄ciently retained on the p13suc1 beads.
Moreover, to investigate whether we could extend these re-
sults to the interaction of CDC2aAt.DL50 with the A. thali-
ana suc1/CKS1 homologue CKS1At [9], we performed an in
vivo two hybrid assay using CDC2aAt.DL50 as bait and
CKS1At as prey. The strain producing both the bait and
the prey is able to grow on the selective medium only if the
two proteins interact. In contrast to the wild-type CDC2aAt
protein, the CDC2aAt.DL50 was unable to associate with the
CKS1At protein in the two hybrid system (Fig. 4: compare
sectors 1 and 4). However, CDC2aAt.DL50 could still asso-
ciate with two other proteins known to interact with
CDC2aAt, namely CYCD1;1 and the putative substrate
TH65 (Fig. 4: sectors 2, 5, and 3, 6 respectively, [20]). These
results demonstrate that the deletion of three amino acids in
CDC2aAt.DL50 speci¢cally abolishes the binding of CKS1At.
4. Discussion
Here we have compared ¢ve mutant alleles of the two A.
thaliana CDKs, CDC2aAt and CDC2bAt, in ¢ssion yeast. The
results obtained can be summarized as follows: (i) only
CDC2aAt and CDC2aAt.AF were able to complement the
temperature sensitive mutant cdc2-33 yeast strain. (ii) The
DL50 mutation in both CDC2aAt and CDC2bAt gave rise
to similar mitotic catastrophe phenotypes, though with appar-
ently di¡erent mechanisms. Moreover, the mutation identi¢es
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Fig. 4. In vivo interaction of CDC2aAt and CDC2aAt.DL50 with
CKS1At. The yeast two hybrid system was used to compare the in-
teraction of CDC2aAt.DL50 (sectors 1 through 3) and CDC2aAt
(sectors 4 through 6) with CKS1At (sectors 1 and 4), and with two
other A. thaliana proteins known to bind CDC2aAt, CYCD1;1 (sec-
tors 2 and 5) and the TH65 protein (sectors 3 and 6).
Fig. 3. In vitro interaction of CDC2aAt and CDC2aAt.DL50 with
suc1. Proteins were prepared from the strains expressing either
CDC2aAt.DL50 or CDC2aAt and were used for p13suc1 agarose af-
¢nity chromatography. The proteins retained on the beads were an-
alyzed by immunoblotting with a CDC2aAt-speci¢c antibody.
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an important site for the interaction with the suc1/CKS1
docking factors. (iii) Two mutations, CDC2aAt.DN and
CDC2aAt.DL36, abolished the kinase activity of CDC2aAt
and the expression of the corresponding mutant proteins ar-
rested yeast cells in G2. (iv) Expression of CDC2aAt.DL41
interfered with the progression through mitosis. (v) All
CDC2bAt mutant alleles, except for CDC2bAt.DL50, caused
a cell cycle arrest in G2, accompanied by an increase in the
size of the nuclei in case of the CDC2bAt.DN mutant.
Two mutant forms of CDC2aAt, CDC2aAt.DN (substitu-
tion of Asn-146 for Asp-146) and CDC2aAt.DL36 (substitu-
tion of Ile-166 for Thr-166) were found to be catalytically
inactive in yeast cell extracts. The Asp-146 residue belongs
to the triad of catalytic residues universally conserved in all
eukaryotic protein kinases (Lys-33, Glu-51 and Asp-145 in the
human CDK2). All three residues provide vital contacts for
correct ATP orientation and Mg2 coordination [21]. The
Thr-166 residue is located amidst the residues, which were
deduced from the three dimensional structure of the fully
activated CDK2, to accommodate the substrate [22].
Both CDC2aAt.DN and CDC2aAt.DL36 are therefore ex-
pected to behave as dominant negative mutants reducing the
total CDK activity by sequestering important regulators of
the yeast cdc2 protein. Indeed, when expressed in yeast,
both CDC2aAt.DN and CDC2aAt.DL36 caused a tight cell
cycle arrest, similarly to the yeast cdc2.DN and cdc2.DL36
genes [16]. Whereas for both yeast mutants the cell cycle arrest
was followed by endoreduplication, our results provide an
indication for endoreduplication (the appearance of grossly
enlarged nuclei upon prolonged expression) only in case of
CDC2aAt.DN expression. Expression of CDC2aAt.DN in to-
bacco caused a reduction in H1 kinase activity, accompanied
by a decrease in the number of cells and an increase of the cell
sizes [5]. Thus, the phenotype described in planta is consistent
with that observed for cdc2.DN and CDC2aAt.DN expression
in yeast, with the exception of lack of endoreduplication.
Because CDC2bAt is catalytically inactive when expressed
in S. pombe, we did not expect a priori any speci¢c pheno-
types associated with the expression of CDC2bAt.DN and
CDC2bAt.DL36. Therefore, it was surprising to ¢nd that
CDC2bAt.DN conferred a much more severe cdcÿ phenotype
to S. pombe cells compared to the wild-type protein. The
observed di¡erence in the behavior of CDC2bAt and
CDC2bAt.DN could be accounted for by an increased stabil-
ity of the complexes formed by CDC2b.DN with limiting cell-
cell regulators.
In contrast, expression of wild-type CDC2aAt, CDC2aA-
t.AF and CDC2aAt.DL50 forced cells to divide at a smaller
size, probably because of a precocious entry into mitosis, with
the severity of the phenotype ranging from a moderate wee
phenotype for CDC2aAt to a characteristically mitotic catas-
trophe for CDC2aAt.DL50.
Similarly to CDC2aAt, a wee phenotype was also observed
when the ¢ssion yeast cdc2 gene was expressed in yeast [23].
Although kinase activity measurements in the cdc2-L7 strain
showed that CDC2aAt is catalytically active in yeast cells, its
expression in the cdc2-33 background resulted in a reduction
of the total CDK activity. These apparently contradictory
results can be reconciled by assuming that the CDC2aAt ki-
nase interacts ine⁄ciently with yeast cell cycle regulators,
leading to the formation of complexes with a speci¢c kinase
activity lower than that of the endogenous cdc2 complexes.
The Thr-14 and Tyr-15 residues are located in the L2 loop
forming the ATP-binding interface in the amino-terminal lobe
of active CDKs [21]. Their phosphorylation is expected to
interfere with the correct positioning of ATP through steric
hindrance and electrostatic repulsion. Inhibitory phosphoryla-
tion of Tyr-15 (or Tyr-15 and Thr-14) has been shown to be
important for the timing of mitosis in many, but not all,
eukaryotes [24]. The involvement of the inhibitory phospho-
rylation in the cell cycle control in plants has been a matter of
controversy [5,25]. Here we present an additional evidence for
the relevance of Tyr-15 phosphorylation for the regulation of
the kinase activity of plant CDKs. Yeast cells overproducing
CDC2aAt.AF, in which both Thr-14 and Tyr-15 were substi-
tuted for two non-phosphorylatable residues, showed an in-
crease in the total histone H1 kinase activity. These results
provide further support for the negative regulation of
CDC2aAt activity by the phosphorylation of the Tyr-15 resi-
due, as it has been demonstrated for PSTAIRE kinases from
tobacco [25].
Of the three amino acids deleted in the cdc2.DL50, on-
ly Asp-242 is conserved in functional cdc2 homologues of
other eukaryotes. Surprisingly, the expression of both
CDC2aAt.DL50 and CDC2bAt.DL50 induced a similar phe-
notype: cells entered mitosis inappropriately at a reduced size
and eventually lost genome integrity. Such a phenotype is very
similar to the mitotic catastrophe described for the yeast
cdc2.DL50 mutant, which was shown to be caused by a pre-
mature onset of mitosis in cells that have not completed DNA
replication. Therefore both A. thaliana DL50 mutants prob-
ably also cause a mitotic catastrophe by triggering entry into
mitosis directly from the S phase. However, the mechanisms
involved might be di¡erent: whereas CDC2aAt.DL50 retains
a high level of kinase activity, no activity can be found asso-
ciated with CDC2bAt.DL50. Thus, the mitotic catastrophe
phenotype conferred by CDC2bAt.DL50 cannot be explained
by a simple gain of function mechanism but rather involves
interference with the normal cell cycle controls of the endog-
enous cdc2. On the contrary, the high speci¢c kinase activity
associated with CDC2aAt.DL50 suggests that it can be di-
rectly responsible for the premature activation of mitosis.
We have also shown that the DL50 mutation identi¢es a
region of primary importance for the interaction with the
suc1/CKS1 proteins. The crystal structure of the human
CDK2 in complex with CKS1Hs indeed showed that the resi-
dues deleted in the DL50 mutants are located in a region
forming the interaction interface for CKS1Hs [18]. Although
the molecular details of the interaction are likely to vary de-
pending on the particular complex, the overall structure of the
interface should be well conserved, given the ability of CDKs
and suc1/CKS1 proteins from di¡erent species to form stable
complexes. One of the possibilities is that suc1/CKS1 modu-
lates indirectly the Tyr-15 phosphorylation through the action
of another protein. This would be consistent with the current
view that the suc1/CKS1 protein mediates the interaction be-
tween CDKs and phosphoproteins [18]. Bourne et al. [18] also
noticed the possibility for CKS1Hs to interfere with the acti-
vating Thr phosphorylation in the T loop. In both cases, the
elimination of association with suc1 could contribute to pre-
mature activation of CDC2aAt.DL50. Alternatively, the
DL50 mutation could act with a mechanism entirely inde-
pendent of suc1 identifying, for instance, a site of interaction
with a CDK inhibitor.
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The Pro-162 residue of the yeast cdc2 protein, substituted
with Leu-162 in the DL41 mutants, is found in all functional
homologues of cdc2 in other eukaryotes, but is not universally
conserved among other CDK proteins. Expression of
cdc2.DL41 in ¢ssion yeast induced an anaphase arrest by spe-
ci¢cally preventing sister chromatids disjunction. Whereas ex-
pression of CDC2bAt.DL41 in ¢ssion yeast blocked the cells
in G2, CDC2aAt.DL41 expression caused an e¡ect similar to
that described for cdc2.DL41. Moreover, the ¢nding that the
mutation of Pro-156 to Leu-156 in CDC2aAt negatively in-
£uences the activity of the enzyme further suggests analogy
with cdc2.DL41. Taken together, these observations indicate
that the A. thaliana PSTAIRE kinase retains at least some of
the functions necessary for progression through mitosis in
yeast, suggesting that it may be involved in mitosis in plants
as well.
Our mutational analysis lends further support for
CDC2aAt being the true orthologue of the yeast cdc2 as all
the mutations tested in the present study induced a phenotype
similar to those described for the homologous mutations in
cdc2. Taken together, these data suggest that the functions
shared by ¢ssion yeast cdc2 and CDC2aAt include regulation
of the G1/S and G2/M transition points, G2 phase progres-
sion and sister chromatid separation.
CDC2bAt, even though quite divergent from ¢ssion yeast
cdc2, still retains the ability to interact with at least some
essential cell cycle regulators suggesting certain functional ho-
mology with the yeast protein. This can be deduced from the
G2 arrest imposed by the expression of CDC2bAt and the
accompanying decrease in the histone H1 kinase activity.
On the other hand, we failed to detect any activity associated
with CDC2bAt in ¢ssion yeast. A plausible interpretation of
these observations could be that CDC2bAt interacts with
components of the yeast cell cycle mechanism essential for
the G2/M transition, most probably cyclins, but the com-
plexes formed are inactive. The suggested interaction of
CDC2bAt with G2/M transition regulators is in agreement
with its expression pattern in plants, where CDC2bAt activity
peaks at the G2/M transition point (G. Segers, unpublished
data). We are currently analyzing the e¡ects of overexpression
of the CDC2aAt and CDC2bAt mutant genes in transgenic A.
thaliana and tobacco plants.
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